Ionis Pharmaceuticals Inc
- Stock
- Ticker IONS
- ISIN US4622221004
- Nasdaq
Performance, volatility and drawdowns of Ionis Pharmaceuticals Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $5,807. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −70.4% in 04/2025, measured from the peak in 04/2019. It took 82 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 227 | 132 | 452 | 157 | 203 | 246 | 268 | 243 |
| Gross profit | 223 | 130 | 448 | 154 | 195 | 243 | 265 | 239 |
| Operating income | -111 | -147 | 140 | -160 | -214 | -117 | -102 | -131 |
| EBITDA | -109 | -145 | 142 | -158 | -211 | -114 | -99 | -127 |
| Net income | -104 | -147 | 124 | -129 | -229 | -93 | -115 | -110 |
| Earnings per share | -0.66 | -0.93 | 0.70 | -0.80 | -1.41 | -0.56 | -0.69 | -0.66 |
| Balance sheet | ||||||||
| Total assets | 3,004 | 2,813 | 2,985 | 3,033 | 3,524 | 3,450 | 2,995 | 2,913 |
| Liabilities | 2,415 | 2,337 | 2,353 | 2,415 | 3,035 | 2,959 | 2,555 | 2,519 |
| Equity | 588 | 476 | 632 | 618 | 489 | 491 | 440 | 394 |
| Cash | 242 | 264 | 297 | 338 | 372 | 173 | 350 | 296 |
| Long-term debt | 1,202 | – | – | – | 1,328 | – | – | – |
| Cash flow | ||||||||
| Operating cash flow | -116 | -151 | 151 | -131 | -138 | -793 | 566 | -179 |
| Capital expenditure | -25 | -13 | -12 | -5.3 | -21 | -22 | -16 | -13 |
| Free cash flow | -142 | -163 | 139 | -137 | -159 | -815 | 549 | -192 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +126.3%, weakest 2021 at −46.2%. 6 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 9 Nov 2026 | −$0.66 |
| 29 Jul 2026 | −$0.69 |
| 29 Apr 2026 | −$0.56 |
| 26 Feb 2026 | −$1.41 |
| 29 Oct 2025 | −$0.80 |
| 30 Jul 2025 | $0.70 |
| 30 Apr 2025 | −$0.93 |
| 19 Feb 2025 | −$0.66 |
| 6 Nov 2024 | −$0.95 |
| 1 Aug 2024 | −$0.45 |
| 7 May 2024 | −$0.98 |
| 21 Feb 2024 | −$0.06 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €4.0bn
- Market cap in trading currency
- $4.43bn
- Enterprise value
- $2.54bn
- P/E
- –
- P/S
- 4.61
- P/B
- 11.25
- EV/Sales
- 2.65
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -13.9%
Results (last four quarters)
- Revenue
- $960m
- Gross profit
- $943m
- EBITDA
- −$551m
- Net income
- −$547m
- Earnings per share
- −$3.32
- Revenue per share
- $5.76
- Revenue growth
- +54.9%
- Earnings growth
- –
Profitability
- Gross margin
- 98.2%
- Operating margin
- -58.8%
- Net margin
- -56.9%
- Return on equity
- -108.1%
- Return on assets
- -18.8%
Balance sheet and cash flow
- Cash
- $1.88bn
- Cash per share
- $11.31
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 5.43
- Book value per share
- $2.36
- Operating cash flow
- −$544m
- Free cash flow
- −$616m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 167m
- Volume
- 3.18m
- Avg. volume 3 months
- 3.85m
- Relative volume
- 0.8
Price and technicals
- Price
- $26.58
- 1 day
- −2.4%
- 52-week high
- $86.50
- 52-week low
- $26.58
- Distance to 52-week high
- −69.3%
- Distance to 52-week low
- 0.0%
- Distance to 50-day line
- −34.8%
- Distance to 200-day line
- −57.9%
- RSI (14)
- 22
- Volatility 1M
- 94.0%
Performance
- 1 week
- −8.5%
- 1 month
- −39.5%
- 3 months
- −57.2%
- 6 months
- −64.8%
- YTD
- −66.4%
- 1 year
- −64.1%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has IONS performed since 11/2016?
$10,000 grew to $5,807 by 20 Nov 2026, which is −5.3% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is IONS?
Volatility was 40.8% per year, measured on monthly returns. The largest decline from a peak was −70.4%, with the low in 04/2025.
How does IONS compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, IONS returned −5.3% at 40.8%. The correlation of monthly returns was 0.28; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.